Background: Alpha-fetoprotein (AFP) has been widely used as a tumor marker in the
treatment of hepatocellular carcinoma (HCC) in patients with cirrhosis. However, a large …

Purpose This study aimed to investigate the prognostic value of alpha-fetoprotein (AFP) ratio
in patients with AFP-negative hepatocellular carcinoma (HCC). Patients and Methods We …

Introduction Alpha‐fetoprotein (AFP) has a valuable role in postoperative surveillance for
hepatocellular carcinoma (HCC) recurrence. The utility of pretreatment or baseline AFP …

Objective To study the relationship between preoperative serum a-fetoprotein (AFP) level
and early recurrence of patients with hepatocellular carcinoma (HCC) after partial …

AIM: To investigate the biological role of alpha fetoprotein (AFP) and its clinical significance
in carcinogenesis of hepatocellular carcinoma (HCC). METHODS: Clinical analysis of HCC …

Introduction: serum alpha-fetoprotein (AFP) was routinely employed as a tumor marker for
screening, diagnosis, and treatment follow-up of hepatocellular carcinoma (HCC). However …

The prognostic impact of serum α-fetoprotein (AFP) level in patients with hepatocellular
carcinoma (HCC) is controversial. This study aimed to investigate the predictive ability of …

Background Preoperative α-fetoprotein (AFP) levels may have an influence on disease-free
survival (DFS) of patients after liver transplantation for hepatocellular carcinoma (HCC) …

Background Assessing the outcomes of surgeries for hepatocellular carcinoma (HCC)
patients who exceed the Milan criteria is necessary. Some studies have demonstrated that …

Background The implication of extremely high preoperative alpha-fetoprotein (AFP) values
for the long-term outcomes of hepatectomy for resectable hepatocellular carcinoma (HCC) …